SUBSIDIARY GUARANTEESubsidiary Guarantee • February 22nd, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 22nd, 2008 Company Industry JurisdictionTHIS SUBSIDIARY GUARANTEE, dated as of February 21, 2008 (this “Guarantee”), is by and among each of the undersigned subsidiaries (together with any other entity that may become an additional guarantor hereunder, the “Guarantors”) of Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and CD Financial, LLC, in its capacity as collateral agent (in such capacity, the “Collateral Agent”), for the benefit of CD Financial, LLC (“Investor” and collectively with their permitted successors and assigns, the “Holders”) of the 9.5% Convertible Senior Secured Note (as amended, restated, supplemented or otherwise modified from time to time, the “Note”) issued as of the date hereof, pursuant to the Securities Purchase Agreement, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Securities Purchase Agreement”), by and between the Company and Investor. Capitalized terms used herein and not otherwise defined shall have the resp
SUBSIDIARY GUARANTEESubsidiary Guarantee • February 22nd, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 22nd, 2008 Company Industry JurisdictionTHIS SUBSIDIARY GUARANTEE, dated as of February 21, 2008 (this “Guarantee”), is by and among each of the undersigned subsidiaries (together with any other entity that may become an additional guarantor hereunder, the “Guarantors”) of Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and Imperium Advisers, LLC, in its capacity as collateral agent (in such capacity, the “Collateral Agent”), for the benefit of Imperium Master Fund, Ltd. (“Imperium” and collectively with their permitted successors and assigns, the “Holders”) of the 8% Senior Secured Note (as amended, restated, supplemented or otherwise modified from time to time, the “Note”) issued as of the date hereof, pursuant to the Securities Purchase Agreement, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Securities Purchase Agreement”), by and between the Company and Imperium. Capitalized terms used herein and not otherwise defined shall have the resp